Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.240
+0.060 (5.08%)
At close: Dec 20, 2024, 4:00 PM
1.270
+0.030 (2.42%)
After-hours: Dec 20, 2024, 6:40 PM EST
Enlivex Therapeutics Employees
Enlivex Therapeutics had 71 employees as of December 31, 2021. The number of employees increased by 21 or 42.00% compared to the previous year.
Employees
71
Change (1Y)
21
Growth (1Y)
42.00%
Revenue / Employee
n/a
Profits / Employee
-$266,662
Market Cap
27.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 71 | 21 | 42.00% |
| Dec 31, 2020 | 50 | 14 | 38.89% |
| Dec 31, 2019 | 36 | 5 | 16.13% |
| Dec 31, 2018 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Allurion Technologies | 504 |
| DarioHealth | 294 |
| Pluri | 118 |
| IRIDEX | 111 |
| NextCure | 82 |
| KALA BIO | 43 |
| Calidi Biotherapeutics | 41 |
| LAVA Therapeutics | 37 |
ENLV News
- 10 days ago - Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis - GlobeNewsWire
- 16 days ago - Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis - GlobeNewsWire
- 25 days ago - Join Enlivex Therapeutics' Exclusive Live Investor Webinar and Q&A Session on December 3 - Accesswire
- 5 weeks ago - Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis - GlobeNewsWire
- 7 weeks ago - Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra™ in Patients with Osteoarthritis - GlobeNewsWire
- 3 months ago - Enlivex Announces Positive DSMB Recommendation to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis - GlobeNewsWire
- 4 months ago - GreenPower and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 5 months ago - Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire